An experimental mRNA-based cancer vaccine succeeded in preventing melanoma from coming back or spreading in a large study, partners Merck and Moderna said

The results from a Merck-Moderna partnership validate years of research into a new approach to cancer treatment.

Discover more from RealUS.news